Note 7    Revenue Recognition

The following table represents net sales by product category and other revenue for years ending December 27, 2025, December 28, 2024, and December 30, 2023.

52 Weeks Ended

52 Weeks Ended

52 Weeks Ending

(amounts in thousands)

December 27, 2025

December 28, 2024

December 30, 2023

Grocery

$

4,012,189

81.3

%  

$

3,927,461

82.3

%  

$

3,921,041

83.5

%

Pharmacy

671,749

13.6

603,216

12.6

527,010

11.2

Fuel

248,425

5.0

235,126

4.9

239,665

5.1

Manufacturing

7,010

0.1

8,077

0.2

9,233

0.2

Total net sales

$

4,939,373

100.0

%

$

4,773,880

100.0

%

$

4,696,950

100.0

%

Other revenue

18,336

17,850

17,623

Total revenue

$

4,957,709

$

4,791,730

$

4,714,573

Historical Timeline

Fiscal YearFiled
2025Mar 12, 2026Showing above
2024Feb 26, 2025
2023Feb 28, 2024
2022Mar 1, 2023
2021Mar 10, 2022
2020Mar 11, 2021
2019Mar 12, 2020
2018Mar 14, 2019

About Revenue Disclosures

Revenue disclosures under ASC 606 explain how a company identifies performance obligations, allocates transaction prices, and determines when revenue is recognized. This section is essential for understanding whether reported revenue reflects genuine economic activity or aggressive accounting choices. Analysts examine the mix of point-in-time versus over-time recognition, which directly affects revenue timing and comparability.

Key signals: rising contract liabilities (deferred revenue) suggest strong future revenue visibility, while declining contract assets may indicate slowing project milestones. Watch for variable consideration estimates — rebates, returns, and performance bonuses that require management judgment. Significant changes in disaggregated revenue by geography or product line can reveal shifting business mix before it appears in headline numbers. Compare revenue growth against contract liability growth to assess sustainability, and scrutinize any changes in the timing of recognition that coincide with earnings pressure.